Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Valentino Sudaryo"'
Autor:
Rhogerry Deshycka, Valentino Sudaryo, Nai-Jia Huang, Yushu Xie, Liyan Y. Smeding, Moon Kyung Choi, Hidde L. Ploegh, Harvey F. Lodish, Novalia Pishesha
Publikováno v:
PLoS ONE, Vol 16, Iss 11 (2021)
Low plasma levels of Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) are associated with decreased low-density lipoprotein (LDL) cholesterol and a reduced risk of cardiovascular disease. PCSK9 binds to the epidermal growth factor-like repeat A (EGFA
Externí odkaz:
https://doaj.org/article/6e2cb9ebe8ff46288add6d9019ba5414
Autor:
Nai-Jia Huang, Novalia Pishesha, Jean Mukherjee, Sicai Zhang, Rhogerry Deshycka, Valentino Sudaryo, Min Dong, Charles B. Shoemaker, Harvey F. Lodish
Publikováno v:
Nature Communications, Vol 8, Iss 1, Pp 1-13 (2017)
The therapeutic use of single-chain antibodies (VHHs) is limited by their short half-life in the circulation. Here the authors engineer mouse and human red blood cells to express VHHs against botulinum neurotoxin A (BoNT/A) on their surface and show
Externí odkaz:
https://doaj.org/article/cc5b7658df0d48e1aa16746d22081aea
Autor:
Hidde L. Ploegh, Harvey F. Lodish, Moon Kyung Choi, Liyan Y. Smeding, Yushu Xie, Valentino Sudaryo, Novalia Pishesha, Rhogerry Deshycka, Nai-Jia Huang
Publikováno v:
PLoS ONE, Vol 16, Iss 11, p e0259353 (2021)
PLoS ONE
PLoS ONE, Vol 16, Iss 11 (2021)
PLoS ONE
PLoS ONE, Vol 16, Iss 11 (2021)
Low plasma levels of Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) are associated with decreased low-density lipoprotein (LDL) cholesterol and a reduced risk of cardiovascular disease. PCSK9 binds to the epidermal growth factor-like repeat A (EGFA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b49cead415ecbd7191fb0f5a2f2877bd
https://doaj.org/article/578e74400dc64fdb8e36d78c1909d017
https://doaj.org/article/578e74400dc64fdb8e36d78c1909d017
Autor:
Liyan Y. Smeding, Moon Kyung Choi, Yushu Xie, Rhogerry Deshycka, Hidde L. Ploegh, Valentino Sudaryo, Novalia Pishesha, Nai-Jia Huang, Harvey F. Lodish
Low plasma levels of Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) are associated with decreased low-density lipoprotein (LDL) cholesterol and a reduced risk of cardiovascular disease. PCSK9 binds to the epidermal growth factor-like repeat A (EGFA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cfbcfc85489bd41752e1528437a8d7d7
https://doi.org/10.1101/2020.11.02.364620
https://doi.org/10.1101/2020.11.02.364620
Autor:
Charles B. Shoemaker, Novalia Pishesha, Harvey F. Lodish, Rhogerry Deshycka, Jean Mukherjee, Sicai Zhang, Min Dong, Valentino Sudaryo, Nai-Jia Huang
Publikováno v:
Nature Communications, Vol 8, Iss 1, Pp 1-13 (2017)
Nature Communications
Nature Communications
A short half-life in the circulation limits the application of therapeutics such as single-domain antibodies (VHHs). We utilize red blood cells to prolong the circulatory half-life of VHHs. Here we present VHHs against botulinum neurotoxin A (BoNT/A)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2542001f6c699c470fdae100fc58e4a2
https://doaj.org/article/cc5b7658df0d48e1aa16746d22081aea
https://doaj.org/article/cc5b7658df0d48e1aa16746d22081aea